Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Liquidia (NASDAQ:LQDA) announced that executives Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Chief Business Officer, will provide a business update in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026 at 8:45 a.m. ET. Access to the live webcast and an archived replay for at least 30 days will be available via the Investors section of Liquidia’s website.
Details
News Market Reaction – LQDA
On Sep 1, the day this news came out, LQDA closed 1.83% below the previous close. Our momentum scanner recorded 3 alerts for this stock that day.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Conference edition
- 21st annual
- Wells Fargo Annual Healthcare Conference
- Event date
- September 8, 2026
- Wells Fargo Annual Healthcare Conference
- Event time
- 8:45 a.m. ET
- Fireside chat
- Replay duration
- at least 30 days
- Webcast archive
Historical Context
-
Strong second-quarter revenue, profitability, cash growth, and YUTREPIA prescription expansion
-
Scheduled second-quarter results release and webcast for August 12, 2026
-
Four posters covering YUTREPIA clinical, patient-reported, and caregiver-related topics
-
Inclusion in the S&P SmallCap 600 Index effective before market open
-
Fireside chat scheduled at the Jefferies Global Healthcare Conference
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MORRISVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Chief Business Officer, will provide an update on the company’s business in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026 at 8:45 a.m. ET.
Access to this event will be available on the “Investors” page of Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A replay of the webcast will be archived on the Company's website for at least 30 days.
About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases through precise, innovative therapies and applications of its proprietary PRINT® technology. PRINT enabled the development of YUTREPIA® (treprostinil) inhalation powder for the treatment of PAH and PH-ILD. The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit www.liquidia.com.
Contact Information
Investors:
Jason Adair
Chief Business Officer
919.328.4350
Jason.adair@liquidia.com
Media:
media@liquidia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.